ST Pharm Co.,Ltd. (KOSDAQ:A237690) announced that it will issue series 1 unregistered non-guaranteed private convertible bonds for gross proceeds of KRW 110,000,000,000 on December 7, 2020. The bonds will be issued at par. The transaction will include participation from NH Synergy IV Bio New Technology Business Fund for KRW 47,500,000,000 and new investor IBKC J&B Biotechnology Business Fund for KRW 62,500,000,000. The bonds will bear interest rate of 0% per annum. The bonds will mature on December 11, 2025. The bonds are convertible into 1,120,356 common shares at a fixed conversion price of KRW 98,183 per share from December 11, 2021 to November 11, 2025. The date of subscription is December 9, 2020 and expected date of payment is December 11, 2020. The transaction is approved by the board of directors of the company.